icone plus
Contact Abonnez-vous aux actualités
Reason for request
Inclusion
Clinical Benefit
Substantial
Substantial actual benefit
Clinical Added Value
no clinical added value
EYLEA 40 mg/ml, solution for injection in a prefilled syringe and solution for injection in a vial, does not provide an improvement in actual benefit (IAB V) compared with LUCENTIS 10 mg/ml, solution for injection.
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
uBHYWPUdnfKhsVcM
Listen
